Biomarkers are biological indicators used to measure the effects of a treatment or the progression of a disease. In clinical trials, biomarkers can serve as surrogate endpoints, helping to predict clinical outcomes and accelerate the drug development process. Genomic, proteomic, and metabolomic analyses are often employed to identify and quantify biomarkers.
